Paeds SAQs · cardiology
Postural orthostatic tachycardia syndrome — formative SAQs
Two formative SAQs on postural orthostatic tachycardia syndrome in young people: a 15-year-old girl with four months of daily orthostatic symptoms meeting POTS criteria, testing the standing-test thresholds, the cardiac-exclusion step and the stepwise non-pharmacological management; and a 14-year-old boy who collapses sprinting with no prodrome and a family history of sudden death, testing the recognition that this is not POTS and the urgent cardiac work-up.
On this page & tools
Target exams
SAQ 1 — The adolescent girl with chronic daily orthostatic symptoms (10 marks)
Stem. A 15-year-old girl presents with four months of daily lightheadedness, palpitations, fatigue and difficulty concentrating that come on within minutes of standing and ease when she lies down. She felt well before this and recalls a viral illness at the onset. She has missed several weeks of school. On a supervised 10-minute active stand test her heart rate rises from 76 supine to 124 bpm upright, and her blood pressure stays at 108/68 mmHg throughout. Examination is normal and she has no family history of sudden death. [1]
Task. (a) State the diagnosis and the specific criteria that confirm it. (b) List the cardiac red-flag features that must be excluded before settling on this diagnosis. (c) Outline the stepwise management. [3]
Model answer
(a) Diagnosis and criteria (3 marks). The diagnosis is postural orthostatic tachycardia syndrome (POTS). The criteria are: chronic orthostatic intolerance on most days for ≥3 months; symptoms provoked by standing and eased by lying down; a heart-rate rise of ≥40 bpm in adolescents (≥30 bpm in adults, or an upright rate ≥120 bpm) within 10 minutes of standing or head-up tilt; and no orthostatic hypotension (no systolic fall ≥20 mmHg or diastolic fall ≥10 mmHg). This child meets all four. [1] [2]
(b) Cardiac red flags to exclude (3 marks). POTS does not cause collapse, so before settling on it you exclude: exertional syncope; syncope while supine or swimming; syncope provoked by a loud noise or fright; syncope with no prodrome; palpitations at the moment of collapse; chest pain or dyspnoea; and a family history of sudden death before about 50 years of age or a known inherited arrhythmia. A 12-lead ECG is obtained on every child. [3] [1]
(c) Stepwise management (4 marks). Step 1: educate, validate and reassure (POTS is real and treatable), keep a symptom and standing diary, and put a school plan in place. Step 2: hydration and salt — around 2–3 L of fluid and titrated sodium chloride per day, avoiding excess salt in hypertension or renal disease. Step 3: physical counter-pressure manoeuvres and compression garments. Step 4: structured recumbent or sub-threshold exercise to reverse the deconditioning spiral — the most evidence-based component. Step 5: phenotype-guided pharmacotherapy (midodrine, fludrocortisone, beta-blocker or ivabradine) only if non-drug measures are insufficient. Treat sleep, mood and school return in parallel. [5] [10]
You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References5Show ledgerHide ledger
- [1]Sheldon RS; Grubb BP; Olshansky B; et al 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm, 2015.PMID 25980576
- [2]Vernino S; Stiles LE; Low P; et al Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1. Auton Neurosci, 2021.PMID 34144933
- [3]Olshansky B; Cannom D; Fedorowski A; et al Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment. Prog Cardiovasc Dis, 2020.PMID 32222376
- [5]Boris JR Postural orthostatic tachycardia syndrome in children and adolescents. Auton Neurosci, 2018.PMID 29778304
- [10]Mar PL; Raj SR Postural Orthostatic Tachycardia Syndrome: Mechanisms and New Therapies. Annu Rev Med, 2020.PMID 31412221